➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Medtronic
McKinsey
Colorcon
Merck
Express Scripts
Moodys

Last Updated: May 11, 2021

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR EVICEL FIBRIN SEALANT (HUMAN)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

All Clinical Trials for EVICEL FIBRIN SEALANT (HUMAN)

Trial ID Title Status Sponsor Phase Start Date Summary
NCT01226914 A Trial Comparing Wound Drainage and Post-operative Complications With and Without the Use of EVICEL™ Fibrin Sealant in Thyroidectomy Completed Ethicon, Inc. N/A 2010-06-01 Primary Objectives - To compare the amount of post-operative wound drainage between the group of patients in which EVICEL™ spray is utilized (Arm A), and the group of patients in which an EVICEL™ placebo is utilized (Arm B). - To compare the length of time to drain removal between Arm A and Arm B. Secondary objectives - To compare the incident or rates of seroma, hematoma, and post-operative edema between the two groups. - To compare the reported pain experienced in each group at selected time points using a standard numerical rating scale (NRS). - To compare the length of hospital stay between the two groups of patients.
NCT01226914 A Trial Comparing Wound Drainage and Post-operative Complications With and Without the Use of EVICEL™ Fibrin Sealant in Thyroidectomy Completed Medical University of South Carolina N/A 2010-06-01 Primary Objectives - To compare the amount of post-operative wound drainage between the group of patients in which EVICEL™ spray is utilized (Arm A), and the group of patients in which an EVICEL™ placebo is utilized (Arm B). - To compare the length of time to drain removal between Arm A and Arm B. Secondary objectives - To compare the incident or rates of seroma, hematoma, and post-operative edema between the two groups. - To compare the reported pain experienced in each group at selected time points using a standard numerical rating scale (NRS). - To compare the length of hospital stay between the two groups of patients.
NCT01235715 The Use of Evicel to Reduce Blood Loss in Total Knee Replacement Surgery Completed Ethicon, Inc. Phase 4 2010-09-01 Application of "Evicel" hemostatic matrix during operation for unilateral total knee replacement surgery (TKA) will result in decreased bleeding and postoperative drain output, a reduction in transfusion requirements, and less reduction of hemoglobin.
NCT01235715 The Use of Evicel to Reduce Blood Loss in Total Knee Replacement Surgery Completed Hospital for Special Surgery, New York Phase 4 2010-09-01 Application of "Evicel" hemostatic matrix during operation for unilateral total knee replacement surgery (TKA) will result in decreased bleeding and postoperative drain output, a reduction in transfusion requirements, and less reduction of hemoglobin.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for EVICEL FIBRIN SEALANT (HUMAN)

Condition Name

Condition Name for EVICEL FIBRIN SEALANT (HUMAN)
Intervention Trials
Hereditary Hemorrhagic Telangiectasia (HHT) 2
Osteoarthritis 1
Goiter 1
Total Knee Replacement 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for EVICEL FIBRIN SEALANT (HUMAN)
Intervention Trials
Epistaxis 2
Osteoarthritis 2
Telangiectasis 2
Telangiectasia, Hereditary Hemorrhagic 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for EVICEL FIBRIN SEALANT (HUMAN)

Trials by Country

Trials by Country for EVICEL FIBRIN SEALANT (HUMAN)
Location Trials
United States 3
Italy 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for EVICEL FIBRIN SEALANT (HUMAN)
Location Trials
California 2
New York 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for EVICEL FIBRIN SEALANT (HUMAN)

Clinical Trial Phase

Clinical Trial Phase for EVICEL FIBRIN SEALANT (HUMAN)
Clinical Trial Phase Trials
Phase 4 1
Phase 3 1
Phase 2 2
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for EVICEL FIBRIN SEALANT (HUMAN)
Clinical Trial Phase Trials
Completed 3
Unknown status 2
Not yet recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for EVICEL FIBRIN SEALANT (HUMAN)

Sponsor Name

Sponsor Name for EVICEL FIBRIN SEALANT (HUMAN)
Sponsor Trials
University of California, San Diego 2
Ethicon, Inc. 2
Hospital for Special Surgery, New York 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for EVICEL FIBRIN SEALANT (HUMAN)
Sponsor Trials
Other 6
Industry 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Medtronic
Mallinckrodt
Express Scripts
Boehringer Ingelheim
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.